Exim Pharma sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-11-27
Share capital
100,000.00 PLN
Activity description

EXIM Pharma provides contract manufacturing of dietary supplements, medical devices and nutritional products for people and animals, including private-label brands. Its range includes probiotics in drops and capsules, vitamins, herbal preparations, tablets, hard and soft capsules, and hard capsules with liquid fillings. Products are made from customer-supplied recipes or the company’s own formulas, with additional services including encapsulation, tableting, coating, and product notification and registration.

Registered address
ul. Ogrodowa 37/50, 00-873 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-21937-30159-SRWUS-25

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$970,721

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 90 days for 2021). 4 of 6 audited by a statutory auditor.

  • 202519/06/2026
  • 202410/07/2025
  • 202311/07/2024
  • 202229/08/2023
  • 202113/10/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing2,324 / 24,649
Top 9.4%
City · Warszawa1,976 / 56,955
Top 3.5%
Voivodeship · Mazowieckie2,670 / 77,195
Top 3.5%
Country · Poland8,898 / 298,026
Top 3.0%

Results vs industry

Revenue
This companyUSD 24.69mMedianUSD 917.74kAverageUSD 25.93m
Net profit
This companyUSD 3.60mMedianUSD 14.44kAverageUSD 2.78m
Operating costs
This companyUSD 20.01mMedianUSD 860.03kAverageUSD 21.46m
Assets
This companyUSD 19.83mMedianUSD 911.84kAverageUSD 31.78m

Offer

Certifications: GMP, ISO 22000

Websites

The site is available in: Polish and English.

  • eximpharma.euProducent suplementów diety, odżywek i wyrobów medycznych | Exim Pharma
    WooCommerceWordPress 3.7Google AnalyticsGoogle Tag ManagerYoast SEOLiteSpeed

Trademarks

The company holds 6 active trademarks registered with the Polish Patent Office. The first mark was filed in 2016.

MarkNumberClassesStatusProtected until
HERBISOUL Z.5519805Protected Feb 1, 2033
proMUM Z.5302455Protected Jun 15, 2031
exim pharma LABORATORIES Goodvit Z.4985865Protected Apr 10, 2029
Rainbovit baby DIETARY SUPPLEMENT Z.4859745, 32Protected May 15, 2028
VigoONE XL men’s sexual health dietary supplement Z.4859755Protected May 15, 2028
MarkProtected until
HERBISOUL Feb 1, 2033
proMUM Jun 15, 2031
exim pharma LABORATORIES Goodvit Apr 10, 2029
Rainbovit baby DIETARY SUPPLEMENT May 15, 2028
VigoONE XL men’s sexual health dietary supplement May 15, 2028

Job offers

The company lists 6 job openings on its own careers page: eximpharma.eu/praca.

Position
Unsolicited application
Process engineer
Shift manager

Authorized Representatives

Agata Załęska age 48 – Attorney-in-fact (joint)
Igor Matus age 46 – Management Board Member
Marcus Kaiser – Attorney-in-fact (joint)
Michał Krzywina age 46 – Management Board Member

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Sunday Natural Products Gmbh
2,000$27,012.43100%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2015-12-10.

  • mBank
    98 1140 1094 0000 2434 7000 1005
  • mBank
    12 1140 1094 0000 2434 7000 1001
  • mBank
    82 1140 1094 0000 2434 7000 1002

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$611.7K
Buildings and premises
$4M

Public aid

19 public aid cases recorded, with a total value of $1,402,769.

PurposeGross amount
Regional investment aid
$206.7K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$858
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,253

European Funds

ProjectEU co-financing
Promotion of Exim Pharma in foreign markets in connection with Poland’s participation in Expo 2020
$56,907
Development of EXIM PHARMA through promotion in international markets.
$87,120

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Prosuplement Group sp. z o.o.
Curtis Health Caps S.A.
Efferta Pharma sp. z o.o.
Zakłady Farmaceutyczne Colfarm S.A.
Global Pharma Cm S.A.
Master Pharm S.A.
Europharma Alliance sp. z o.o.
Valentis Polska sp. z o.o.
Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o.
Medicofarma S.A.

Change history

DateEvent
2022-12-08PKD change
2021-08-18Share capital increase
2015-11-27Entered in the register

FAQ

Last updated: 2026-10-07